Price records re-read October 15, 2026 on providers’ own pages · Methodology v4.1 · Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP · Corrections log
GLP1ProviderFinderUS price records
Home › Compare › NexLife vs NovoCare (Wegovy)

Head-to-head

NexLife vs NovoCare (Wegovy): GLP-1 Prices Compared

Released: Last reviewed:

No like-for-like tirzepatide verdict: NovoCare (Wegovy) does not offer tirzepatide.

Only prices read on the providers’ own pages on October 15, 2026 produce a verdict here; older records are shown with their dates and are not compared. Confirm the total at checkout.

Tirzepatide: NexLife vs NovoCare (Wegovy)

Tirzepatide prices from each provider’s own page; read dates in the status row
NexLifeNovoCare (Wegovy)
All-in monthly at maintenance$129/moNot offered
Cheapest 12-month route, per month$115/moNot offered
12-month cost$1,380Not offered
Membership / program feeNoneNot offered
Dose pricingSame price at every dose (plan pages)Not offered
StatusVerified · 2026-11-06Not offered

The arithmetic

No like-for-like tirzepatide verdict: NovoCare (Wegovy) does not offer tirzepatide.

Semaglutide: NexLife vs NovoCare (Wegovy)

Semaglutide prices from each provider’s own page; read dates in the status row
NexLifeNovoCare (Wegovy)
All-in monthly at maintenance$109/mo$349/mo
Cheapest 12-month route, per month$95/mo$349/mo
12-month cost$1,140$4,188
Membership / program feeNoneNone
Dose pricingSame price at every dose (plan pages)Pen $349 at 0.25-2.4 mg; Wegovy HD 7.2 mg $399; new patients $199 for two fills of 0.25/0.5 mg through 12/31/2026; Wegovy pill $149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)
StatusVerified · 2026-11-06Verified · 2026-10-15

The arithmetic

As of November 6, 2026, NexLife’s all-in price at the maintenance dose is $109 a month; on October 15, 2026, NovoCare (Wegovy)’s averaged $349, so NexLife costs $240 less a month on average; NexLife costs $2,880 less over a year of month-to-month billing ($1,308 vs $4,188).

Terms side by side

NexLife

  • BillingMonthly plan, or 3-, 6- and 12-month plans ("Savings applied at checkout on eligible multi-month plans. Plans continue monthly unless canceled.")
  • CancellationCancellations take effect after 30 days, so one more shipment may be charged; on 3-, 6- and 12-month plans unshipped months are refunded (plan pages)
  • PharmacyAbsolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA)

NovoCare (Wegovy)

  • BillingNo subscription; self-pay per fill
  • PharmacyCoAssist Pharmacy d/b/a NovoCare Pharmacy

Questions people ask

Is NexLife or NovoCare (Wegovy) cheaper for semaglutide?

As of November 6, 2026, NexLife’s all-in price at the maintenance dose is $109 a month; on October 15, 2026, NovoCare (Wegovy)’s averaged $349, so NexLife costs $240 less a month on average; NexLife costs $2,880 less over a year of month-to-month billing ($1,308 vs $4,188). Both figures are all-in monthly prices at the maintenance dose, including any membership fee.

What does a year of semaglutide cost at NexLife and NovoCare (Wegovy)?

Using each program’s cheapest published 12-month route: $1,140 at NexLife (as of November 6, 2026) and $4,188 at NovoCare (Wegovy) (read October 15, 2026). Prepaid plans lower the monthly price but raise what you lose if you stop early, so read the refund terms first.

Are compounded GLP-1s from either program FDA-approved?

No compounded tirzepatide or semaglutide is FDA-approved, and neither is a generic version of Zepbound, Mounjaro, Wegovy or Ozempic. Brand products sold by LillyDirect and NovoCare are FDA-approved. Ask which pharmacy fills your prescription and check its state license.

What will checkout show that this page does not?

Taxes, state availability, current promotions and any change made after our read date. Screenshot the order summary before you pay; that screen, not a comparison page, shows what you are agreeing to.

Records: NexLife · NovoCare (Wegovy) · price database · downloads. Official sites: NexLife ↗ · NovoCare (Wegovy) ↗.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.